ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0175

Identifying Immuno-phenotypes in Juvenile Localized Scleroderma with RNA Sequencing

Christina Schutt1, Emily Mirizio2, Kaila Schollaert-Fitch2, Claudia Salgado3, Miguel Reyes-Mugica3 and Kathryn Torok2, 1University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh Medical Center, Pittsburgh

Meeting: ACR Convergence 2020

Keywords: Gene Expression, genomics, Pediatric rheumatology, Scleroderma, Scleroderma, Localized

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Juvenile localized scleroderma (jLS) is an autoimmune disease of the skin and underlying tissue characterized by an early inflammatory infiltrate followed by fibrosis and collagen deposition leading to atrophy.  Uncontrolled jLS results in significant disfigurement and functional disability.  Our goal was to determine the transcriptome within inflammatory and fibrotic LS tissue vs. healthy controls and identify potential molecular targets using RNA sequencing (RNAseq).  Differentially expressed genes (DEGs) identified in jLS patients were compared to histopathological features to determine correlation and were used to cluster LS patients according to common expression pathways.

Methods: RNAseq was performed on paraffin-embedded skin (n=28 jLS, n=10 pediatric healthy) using the Illumina HTS and TrueSeq Access library preparation.  Paired-end RNAseq data was aligned using STAR, corrected for batch effect and analyzed for DEGs using DESeq2.  Genes were analyzed using DEG cutoffs of log fold change > ±2.0, adjusted p< 0.05, and a false discovery rate (FDR) cutoff of < 0.05 for Reactome and enrichment software (GSEA©).  Standardized scoring was developed for inflammation and collagen deposition and was completed between 2 blinded pathologists.  Spearman’s correlation was used to determine significance between DEGs and histology scoring.

Results: We found 589 significant DEGs between jLS vs. pediatric healthy controls with the above cutoffs.  Hierarchical clustering using complete linkage of Euclidean distance demonstrated three distinct jLS groupings; Group 1, Group 2 and Healthy-Like (Figure 1).  In Group 1, 61 DEGs were identified which associate with interferon gamma signaling, MHC class II antigen presentation, and TCR signaling (p< 0.01).  Specifically, five are HLA class II genes, HLA-DQA1, HLA-DQB1, HLA-DRB5, HLA-DPA1, and HLA-DRB1 (p< 0.01, FC >2, FDR< 0.05).  Degree of inflammatory cell infiltrates significantly correlated with HLA-DPB1, HLA-DQA2, HLA-DRA, and STAT1 (rs > 0.5, p< 0.01).  Collagen thickness in upper reticular dermis had a positive correlation with HLA-DQA1 (rs=0.46, p=0.03).  In Group 2, 76 DEGs were identified, which associate with pathways of FGFR1 amplification, collagen formation and keratinization (p< 0.05).

Conclusion: The identified groupings of jLS patients showed two distinct genetic signatures, one with upregulated inflammatory-related pathways, which corresponded to inflammatory infiltrate score, and a second group with upregulated fibrosis-related pathways.  HLA Class II gene upregulation was observed within the inflammatory group, which has also been described for systemic sclerosis.  Interestingly also the immune-phenotype groups did not directly correspond with the patients clinical phenotype.  Further investigation into the relationship and functions of these genes in jLS tissue is underway.

Figure 1: Hierarchical Clustering using complete linkage of Euclidean Distance

Figure 2: Circos plot comparing clinical LS subtype to immune-phenotype clustering.


Disclosure: C. Schutt, None; E. Mirizio, None; K. Schollaert-Fitch, None; C. Salgado, None; M. Reyes-Mugica, None; K. Torok, None.

To cite this abstract in AMA style:

Schutt C, Mirizio E, Schollaert-Fitch K, Salgado C, Reyes-Mugica M, Torok K. Identifying Immuno-phenotypes in Juvenile Localized Scleroderma with RNA Sequencing [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/identifying-immuno-phenotypes-in-juvenile-localized-scleroderma-with-rna-sequencing/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-immuno-phenotypes-in-juvenile-localized-scleroderma-with-rna-sequencing/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology